Following a customer survey, the Alpha Laboratories website has now been completely re-developed and launched on an advanced, fully responsive e-commerce platform.
The modern design and functionality incorporates many of the suggestions received from users, to bring a much easier, more informative and enjoyable online experience. See it now, live at www.alphalabs.co.uk. Built to meet scientists needs, the new website includes intuitive mega menu navigation across the full range of Laboratory, Diagnostic and Research products. Detailed content is presented in an easy to use tabbed format...
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, the University of Birmingham and Cancer Research Technology, the commercialisation arm of Cancer Research UK, announces today the launch of a collaboration to develop a new immuno-oncology cellular therapy based on gene modifying T cells to target solid tumours.
The project is aimed at translating an academic discovery programme funded by Cancer Research UK and developed by Dr Steven Lee and Prof Roy Bicknell at the University of Birmingham into a commercially viable cell therapy.The collaborating partners have launched a new company, Chimeric Therapeutics Ltd. This new company will hold all future IP rights to the resultant discoveries. The project is based on a new...
Axilum Robotics, specializing in the development of medical robots and Rogue Resolutions, a provider of integrated neuroscience solutions, today announced the installation of a robotized system for image-guided Transcranial Magnetic Stimulation (TMS) in the Brain, Mind and Behavior Research Center at University of Granada (CIMCYC-UGR), Spain.
The Brain, Mind and Behavior Research Center at University of Granada (CIMCYCUGR) is a centre for psychological excellence research. It is composed by a pleiade of research teams devoted to the study of all aspects of Psychology, encompassing Clinical and Health Psychology, Human Development, Applied Psychology, Higher Cognitive functions and social interactions. The centre is Home to the Functional Magnetic Resonance Unit of...
Presenting a faster and more efficient alternative to electron microscopy, digital light microscopy has been advancing investigations into the mechanical properties of bone, as explored in a new application note from Olympus.
Unravelling the mechanical properties of bone with micro-indentation testing has significance in both health and disease. At the University Medical Center Hamburg-Eppendorf, Dr. Björn Busse and his research group have advanced their micro-indentation testing technique using an Olympus industrial inspection digital light microscope, as an alternative to electron microscopy. The cutting edge research is described in a new application...
Genomics plc, a leading analysis company developing algorithms and software solutions to uncover the relationships between genetic variation and human disease, today announced that Sekar Kathiresan, M.D., a renowned clinical cardiologist and human geneticist, has joined Genomics plc’s newly-formed Scientific Advisory Board (SAB) as chair, with immediate effect.
Dr Kathiresan is one of the world leaders in the genetics of heart disease. He is the director of preventive cardiology at Massachusetts General Hospital, an associate member in the Broad Institute’s Program in Medical and Population Genetics, and an associate professor of medicine at Harvard Medical School. He received his B.A. in history and graduated summa cum laude from the University of Pennsylvania in 1992. He received his...
Sheffield Teaching Hospitals NHS Trust report ease of use
Beckman Coulter recently commissioned independent system performance trials of the new DxN VERIS Molecular Diagnostics System* and results show that the system is easy to operate with technicians fully operational on the system following just 20 minutes training. Following a trial undertaken at Sheffield Teaching Hospital NHS Trust, UK, Duncan Whittaker, Laboratory Manager Virology,stated “Training staff to use the DxN VERIS...
Xmark Media the organisers of Photonex 2016, the UK's showcase photonics conference & exhibition announce the second biennial conference on hyperspectral imaging and applications.
This FREE-to-attend conference will be held on Wednesday & Thursday 12th and 13th October as part of the growing two-day event at the visitor-friendly Ricoh Arena in Coventry. Following on from a successful event in 2014 where leading scientists from around the world discussed developments in hyperspectral imaging and new applications, this now biennial conference is announced and will re-convene on Wednesday 12th & Thursday 13th October 2016...
Irvine Scientific, a world leader in the innovation and manufacture of cell culture media, reagents, and medical devices for industrial, clinical and research applications, today announced it has acquired BioCare Europe S.r.l. (BioCare).
Based in Rome, Italy, BioCare is a leading distributor of in vitro fertilization (IVF) media, medical devices, and equipment. Irvine Scientific provides the IVF market with cGMP cell culture media which is unrivalled in performance and quality. Supporting IVF hospitals and clinics worldwide, Irvine Scientific has been building a sales presence in Europe over the last several years, focused mainly in the UK, France, and Germany. BioCare is...
Metrohm USA and the University of Maryland School of Pharmacy have recently formed a mutually beneficial partnership.
The alliance will bring state-of-the-art analytical instrumentation and software to the School to be used by students and faculty in a variety of disciplines. The presence of Metrohm at the School of Pharmacy will foster collaboration between Metrohm scientists and the renowned research and education leaders at the School. Collaborative work is already under way in the laboratory of Dr. Stephen Hoag, Professor of Pharmaceutical...
Interest in flow chemistry systems has doubled since 2010 according to UK-based flow chemistry engineering specialists Vapourtec (Cambridge, UK) who experienced a further 15% increase in turnover in 2015.
Vapourtec's turnover over the past 5 years has increased by 100% mirroring key industry reports that reveal an ever growing interest and engagement by chemists around the world in continuous process technology. Vapourtec founder and MD Duncan Guthrie commented: "We've experienced another rapid year of growth and this reflects growing awareness of the benefits and the impressive economies of scale that can be delivered by flow chemistry...
Detailed hematology guide available for free download
EKF Diagnostics, the global in vitro diagnostics company, announces the publication of its new guide, “Anemia and hemoglobin testing” [1]. Available to download for free from ekfdiagnostics.com, the in-depth hematology guide provides a review of the symptoms and causes of anemia, through to methods for testing hemoglobin and hematocrit, as well as factors that may influence these measurements. Anemia is the most common...
NanoHybrids Inc., a nanotechnology and molecular imaging company, recently received $225,000 from the National Cancer Institute (NCI) to develop a new breakthrough immunohistochemistry (IHC) technology.
The project builds on NanoHybrids expertise producing high quality gold nanoparticles that enable innovative approaches to imaging. With this Phase I Small Business Innovation Research (SBIR) grant, NanoHybrids will develop a new photoacoustic microscopy platform to quantitatively assess biomarker distribution in biopsied and histological human samples.
Magritek, a leading provider of compact NMR and MRI instruments, have released new solutions that enable straightforward reaction monitoring on the Spinsolve benchtop NMR spectrometer.
This is complemented with a series of applications notes illustrating the multiple uses for the Spinsolve benchtop NMR spectrometer. The development of benchtop NMR spectroscopy no longer requires specialist high technology systems with specialist laboratories and highly qualified operators. The use of new, cryogen-free magnet technology and a system that is easily used on the lab bench or made readily portable on a...
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study “CHANGE-MS” (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
The study plans to enroll 260 patients in 68 clinical centers in the European Union and Eastern Europe. Preliminary results are expected by the end of 2017. Simultaneous with the start of Phase IIb, development partner Servier has exercised its equity investment option, as part of an agreement signed in November 2014, to become a minority shareholder in GeNeuro by purchasing shares from existing shareholder Eclosion2...
SMi Group Reports: Its 8th annual conference on Adaptive Designs in Clinical Trials will be held in London on the 18th - 19th April 2016.
In recent years, the use of adaptive design methods has become very popular due to its flexibility for identifying clinical benefits of the testing drug. Adaptive designs offer the potential to reduce timelines and patient exposure while maximising the probability for successful outcomes. However, along with these benefits come challenges: additional complexity, needs for advanced statistical models and increased operational demands.
Deben, a leading provider of in-situ testing stages together with innovative accessories and components for electron microscopy, has supplied various tensile stages for use in X-ray computerised tomography (CT) analysis to the CT Scanner Facility at Stellenbosch University in South Africa.
Dr Anton du Plessis is Manager of the CT Scanner Facility at Stellenbosch University in South Africa. The Facility acts as a CT Scan Service provider with the aim to provide a high quality 3D imaging and analysis service, with fast turnaround times. The unit serves clients from both academia and industry from all over South Africa as well as many from overseas. Dr du Plessis talks about the choice of stages and how they are being...
Sakura Finetek USA, Inc. today announced the acquisition of Genemed Biotechnologies Inc.’s (Genemed) tissue-based Advanced Staining business for cancer detection, diagnosis and monitoring.
The deal is expected to be closed by December 31st, 2015. Financial terms of the acquisition were not disclosed. “We are pleased to add Genemed’s highly skilled and expert personnel, production facility and their extensive catalog of antibodies, probes and detection chemistry to Sakura’s product portfolio. The product portfolio offered by Genemed is a perfect complement to Sakura’s hardware and software...
Integrins help cells communicate with and adapt to their environment.
Also cancer cells depend on their properties to survive and spread throughout the body. Now scientists at the Technical University of Munich (TUM) have successfully developed a small, highly active molecule that binds to a specific integrin which operates in many types of cancer. In the future it may allow patient-specific diagnoses and subsequent targeted treatment of tumor cells. Integrins are among the most important links...
Brookfield Engineering, the world standard for viscosity measurement and control, offers its Practical Course on Viscosity Measurements.
This popular course is designed to help Brookfield Viscometer users comprehend the functionality of their instrument, solve the mysteries of fluid behavior and Rheology, and create successful and repeatable viscosity test methods for use in both R&D and QA/QC environments. Consistent measurement is vital in the success of any product and understanding viscosity is a key part to maintaining quality control. The course is offered at...
Genomics’ Proprietary Statistical Analysis Tools and Integrated Multi-Phenotype Database to be used to Support Research and Development at Vertex Pharmaceuticals
Genomics plc, a leading analysis company developing algorithms, data resources, and software solutions to uncover the relationships between genetic variation and human disease, today announced that Vertex Pharmaceuticals will use Genomics’ integrated database and state-of-the-art analysis tools to inform its drug research and development. These tools aim to provide confidence in the rationale for targeting Vertex’s pathways...
‘The results of this study provide reassurance that specialists treating patients with a heart attack can open more than one narrowed artery without increasing the total amount of heart damage.’ Dr Gerry McCann, NIHR Career Development Fellow, University of Leicester & Leicester’s Hospitals
A new study has examined the effects on the heart of treating multiple narrowed arteries - rather than just one – at the time of a heart attack. Specialist heart doctors increasingly treat patients with large heart attacks urgently with a procedure under local anaesthetic. The blocked blood vessel (artery), which causes the heart attack is opened by inserting a small metal scaffold (stent) at the blockage to hold the artery open...
An internationally renowned gene therapy research team has won a $200,000 CytoFLEX Flow Cytometer from Beckman Coulter Life Sciences.
The contest was designed to explore innovative research solutions involving flow cytometry. The winning team, headed up by Dr Martin Pulé, is from UCL Cancer Institute at University College London, UK. Their submission focused on capitalizing on the power of multi-parameter flow cytometry to expand understanding of the molecular mechanisms of cancer at the single cell level. The CytoFLEX Flow Cytometer measures up to...